Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors
Summary: Disruption of antigen presentation via loss of major histocompatibility complex (MHC) expression is a strategy whereby cancer cells escape immune surveillance and develop resistance to immunotherapy. Here, we develop the personalized genomics algorithm Hapster and accurately call somatic mu...
Main Authors: | Michael B. Mumphrey, Noshad Hosseini, Abhijit Parolia, Jie Geng, Weiping Zou, Malini Raghavan, Arul Chinnaiyan, Marcin Cieslik |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124723009762 |
Similar Items
-
MHC class II regulation of CD8+ T cell tolerance and implications in autoimmunity and cancer immunotherapy
by: Xiaojuan Zhou, et al.
Published: (2023-11-01) -
Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity
by: Linyuan Peng, et al.
Published: (2024-04-01) -
MCK2-mediated MCMV infection of macrophages and virus dissemination to the salivary gland depends on MHC class I molecules
by: Berislav Bošnjak, et al.
Published: (2023-06-01) -
PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity
by: Tirta M. Djajawi, et al.
Published: (2024-03-01) -
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
by: Anastasia-Maria Zavitsanou, et al.
Published: (2023-11-01)